Noile-Immune Biotech: 2nd quarter (interim) financial report for the fiscal year ending December 2024 [Japan Standard] (non-consolidated)

JPX · Aug 9 16:45

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.